Aspect Biosystems Announces Partnership with Jdrf to Advance Development of a Bioengineered Tissue Therapeutic to Treat Type 1 Diabetes
Vancouver, BC, Canada and New York, NY – Aspect Biosystems (“Aspect”), a biotechnology company developing bioengineered tissue therapeutics to transform how we treat disease, is pleased to announce a partnership… Read More




